忧郁症治疗药物市场：按药物类型、按适应症、按配销通路、按地区

Depression Therapeutics Market, By Drug Type, By Indication, By Distribution Channel, and By Geography

出版日期: 2023年09月05日 | 出版商:

Coherent Market Insights | 英文 180 Pages | 商品交期: 2-3个工作天内

价格

简介目录

预计2023年全球忧郁症药物市场规模为129亿美元，预测期内（2023-2030年）年复合成长率为4.5%。

报告范围		报告详情
基准年	2022年	2023年市场规模	129亿美元
实绩资料	2018-2021	预测期	2023-2030
预测期年复合成长率	4.50%	2030年市场规模预测	176亿美元

2023 年按药物类型分類的忧郁症药物全球市场占有率(%)

抗忧郁药物是缓解忧郁症状的药物，也用于治疗其他疾病。抗忧郁症可以治疗忧郁症和其他心理健康问题的症状。然而，并非总是能够解决原因。医生经常开抗忧郁症和谈话疗法来解决心理健康问题的根源。抗忧郁症有多种类型。它们作用于几乎相同的大脑化学物质并产生相似的效果。然而，有些抗忧郁症对某些人的效果比其他人更好。

市场动态

製药业的主要参与者透过进行各种临床试验和研究活动来专注于药物的开发。因此，市场参与者活性化的研发活动预计将在预测期内推动全球忧郁症药物市场的成长。例如，2022年11月，专注于为受中枢神经系统疾病罹患的人们恢復希望的生物技术公司Autobahn Therapeutics宣布，将在健康志愿者中开始ABX-002的1期临床给药。 ABX-002是一种甲状腺受体β （ TR Hui）促效剂，对改善脑功能具有很强的抗忧郁症作用，我们正在研究对MDD患者辅助性治疗的可能性。

本次测试的主要特点

本报告详细分析了全球忧郁症治疗药物市场，并提供了以2022年为基准年的预测期（2023-2030）的市场规模和年复合成长率(CAGR)。它揭示了各个细分市场的潜在商机，并解释了该市场有吸引力的投资提案矩阵。
它还提供了有关市场促进因素、抑制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的主要考察。
它根据公司亮点、产品系列、主要亮点、业绩和策略等参数，介绍了全球忧郁症治疗药物市场的主要企业。
该报告的见解使行销人员和公司负责人能够就未来的产品发布、经营团队升级、市场扩张和行销策略做出明智的资讯。
全球忧郁症治疗药物市场报告迎合了该行业的各种相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
透过用于分析全球忧郁症治疗药物市场的各种策略矩阵，将有助于相关人员做出决策。

Report Coverage	Report Details
Base Year:	2022	Market Size in 2023:	US$ 12.9 Bn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	4.50%	2030 Value Projection:	US$ 17.6 Bn

Depression therapeutics are medications that can help relieve the symptoms of depression and are also used in the treatment of some other conditions. Antidepressants can treat the symptoms of depression or other mental health problems. But they don't always deal with the causes. Doctors will often prescribe them alongside talking therapy, to help deal with the causes of mental health problems. There are several different types of antidepressants. They mostly affect the same brain chemicals and cause similar effects. But some people may respond to certain antidepressants better than others.

The different types are:

Selective Serotonin Reuptake Inhibitors (SSRIs)
Serotonin and Noradrenaline Reuptake Inhibitors (SNRIs)
Tricyclics and tricyclic-related drugs
Monoamine Oxidase Inhibitors (MAOIs)
Others

Market Dynamics

The key players in the pharmaceutical industry are focusing on the development of drugs by conducting various clinical trials and research operations. Thus, increasing research and development activities by market players are expected to drive the growth of the global depression therapeutics market over the forecast period. For instance, in November 2022, Autobahn Therapeutics, a biotechnology company focused on restoring hope for people affected by CNS disorders, announced the initiation of dosing in the company's Phase 1 clinical trial of ABX-002 in healthy volunteers. ABX-002 is a potent and selective brain-boosting thyroid receptor beta (TRβ) agonist that Autobahn is evaluating as a potential adjunctive treatment for people with major depressive disorder (MDD) who are experiencing an inadequate response to their antidepressant.

Key features of the study:

This report provides an in-depth analysis of the global depression therapeutics market and provides market size (US$ Billion) and compound annual growth rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global depression therapeutics market based on the following parameters- company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include Johnson & Johnson, GlaxoSmithKline plc., Otsuka Pharmaceutical Co., Ltd., Takeda Pharmaceutical Company Limited., Eli Lilly and Company, Sanofi S.A., Pfizer, Inc., Allergan plc., H. Lundbeck A/S, Alkermes, Allergan, Novartis AG, Biogen, Sage Therapeutics, Inc., and AbbVie Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global depression therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global depression therapeutics market.

Detailed Segmentation:

Global Depression Therapeutics Market, By Drug Type:
- Selective Serotonin Reuptake Inhibitors (SSRIs)
- Selective Norepinephrine Reuptake Inhibitors (SNRIs)
- Serotonin Modulators
- Tricyclic & Tetracyclic Antidepressants
- Atypical Antidepressants
- Antidepressants
- Antipsychotics
- Others
Global Depression Therapeutics Market, By Indication:
- Major Depressive Disorder (MDD)
- Bipolar Disorder
- Dysthymic Disorder
- Postpartum Depression
- Seasonal Affective Disorder (SAD)
- Premenstrual Dysphoric Disorder (PMDD)
- Others
Global Depression Therapeutics Market, By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Depression Therapeutics Market, By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
Company Profiles
- Johnson & JohnsonGlaxoSmithKline plc.
- Otsuka Pharmaceutical Co., Ltd.
- Takeda Pharmaceutical Company Limited.
- Eli Lilly and Company
- Sanofi S.A.
- Pfizer, Inc.
- Allergan plc.
- H. Lundbeck A/S
- Alkermes
- Allergan
- Novartis AG
- Biogen
- Sage Therapeutics, Inc.
- AbbVie Inc.

1. Research Objective and Assumption

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Drug Type
- Market Snippet, By Indication
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics

Drivers
Restraints
Market Opportunities
- Impact Analysis
- Recent Drug Launches
- Epidemiology
- Pipeline Analysis
- Distribution Landscape
- Merger, Acquisition, and Collaborations
- Regulatory Scenario
- Key Developments
- PEST Analysis

4. Global Depression Therapeutics Market - COVID-19 Impact Analysis

Economic Impact
COVID-19 Epidemiology
Impact on Supply and Demand

5. Global Depression Therapeutics Market, By Drug Type, 2018 - 2030, (US$ Bn)

Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018-2030
Segment Trends
Antidepressants
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
Segment Trends
Selective Serotonin Reuptake Inhibitors (SSRIs)
Selective Norepinephrine Reuptake Inhibitors (SNRIs)
Serotonin Modulators
Tricyclic & Tetracyclic Antidepressants
Atypical Antidepressants
Antipsychotics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
Segment Trends
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
Segment Trends

6. Global Depression Therapeutics Market, By Indication, 2018 - 2030, (US$ Bn)

Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018-2030
Segment Trends
Major Depressive Disorder (MDD)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
Segment Trends
Bipolar Disorder
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
Segment Trends
Dysthymic Disorder
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
Segment Trends
Postpartum Depression
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
Segment Trends
Seasonal Affective Disorder (SAD)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
Segment Trends
Premenstrual Dysphoric Disorder (PMDD)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
Segment Trends
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
Segment Trends

7. Global Depression Therapeutics Market, By Distribution Channel, 2018 - 2030, (US$ Bn)

Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018-2030
Segment Trends
Hospital Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)
Online Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Bn)

8. Global Depression Therapeutics Market, By Region, 2018 - 2030, (US$ Bn)

Introduction
Market Share Analysis, 2023 and 2030 (%)
Y-o-Y Growth Analysis, 2018-2030
Segment Trends
North America
Introduction
Market Size and Forecast,Y-o-Y Growth and By Drug Type, 2018 -2030, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By Indication, 2018 -2030, (US$ Bn)
Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Bn)
Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
U.S.
Canada
Europe
Introduction
Market Size and Forecast,Y-o-Y Growth and By Drug Type, 2018 -2030, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By Indication, 2018 -2030, (US$ Bn)
Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Bn)
Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast,Y-o-Y Growth and By Drug Type, 2018 -2030, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By Indication, 2018 -2030, (US$ Bn)
Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Bn)
Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
Introduction
Market Size and Forecast,Y-o-Y Growth and By Drug Type, 2018 -2030, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By Indication, 2018 -2030, (US$ Bn)
Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Bn)
Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
Introduction
Market Size and Forecast,Y-o-Y Growth and By Drug Type, 2018 -2030, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By Indication, 2018 -2030, (US$ Bn)
Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Bn)
Market Size and Forecast, By Country, Y-o-Y Growth and By Country, 2018 -2030, (US$ Bn)
GCC
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast,Y-o-Y Growth and By Drug Type, 2018 -2030, (US$ Bn)
Market Size and Forecast, Y-o-Y Growth and By Indication, 2018 -2030, (US$ Bn)
Market Size and Forecast,Y-o-Y Growth and By Distribution Channel, 2018-2030, (US$ Bn)
Market Size and Forecast, By Country, Y-o-Y Growth and By Country/ Region, 2018 -2030, (US$ Bn)
North Africa
Central Africa
South Africa